Cases & Deals

  • Home
  • Practices
  • Global pharmaceutical company seeks over $1 billion in ICC arbitration related to licensing agreement

Share

Global pharmaceutical company seeks over $1 billion in ICC arbitration related to licensing agreement

October 2019

Client(s) Global pharmaceutical company

Jones Day successfully represented a global pharmaceutical company seeking over $1 billion in a licensing agreement dispute over royalty payments and the application of U.S. Supreme Court decisions in Brulotte and Kimble, among other claims.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.